6-Fluoro-3,3-dimethylindolin-2-one

Catalog No. :
ACTQDK921
CAS No. :
866211-45-2
Molecular Formula :
C10H10FNO
Molecular Weight :
179.19

IUPAC Name:6-fluoro-3,3-dimethylindolin-2-one

6-Fluoro-3,3-dimethylindolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$270.00Login to see priceInquiryInquiry
100mg98%$394.00Login to see priceInquiryInquiry
250mg98%$869.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Fluoro-3,3-dimethylindolin-2-one
IUPAC Name6-fluoro-3,3-dimethylindolin-2-one
MDL No.MFCD13192271
Molecular FormulaC10H10FNO
Molecular Weight179.19
SMILESO=C1NC2=C(C=CC(F)=C2)C1(C)C
InChI KeyPYIOIVVNDDWUBF-UHFFFAOYSA-N
Synonym6-fluoro-1,3-dihydro-3,3-diMethyl-2H-Indol-2-one;6-fluoro-3,3-diMethyl-2,3-dihydro-1H-indol-2-one;6-fluoro-3,3-dimethylindolin-2-one;2H-Indol-2-one, 6-fluoro-1,3-dihydro-3,3-dimethyl-
CAS No.866211-45-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTQDK921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACMXBG978 route compound structure diagram
    --
  6. Then
  7. ACTQDK921 route product structure diagram
    ACTQDK921866211-45-2
Inquiry

2. ACTQDK921 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACTQDK921 route product structure diagram
    ACTQDK921866211-45-2
Inquiry

Comments (0)